E, C., E, V., E, P., A, G., E, B., EA, J., & V, V. E. (2026). Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets. Current heart failure reports, 23(1), . https://doi.org/10.1007/s11897-026-00745-0
Chicago Style (17th ed.) CitationE, Cami, Verghote E, Pecetto E, González A, Brakenhielm E, Jones EA, and Van Empel V. "Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets." Current Heart Failure Reports 23, no. 1 (2026). https://doi.org/10.1007/s11897-026-00745-0.
MLA (9th ed.) CitationE, Cami, et al. "Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets." Current Heart Failure Reports, vol. 23, no. 1, 2026, https://doi.org/10.1007/s11897-026-00745-0.
Warning: These citations may not always be 100% accurate.